Global Emergency Contraceptive Pills Market by Type (Antiprogestin, Combination Pills, Progesterone Pills), Category (Branded, Generic), Age Group, Distribution - Forecast 2024-2030

The Emergency Contraceptive Pills Market size was estimated at USD 1.02 billion in 2023, USD 1.08 billion in 2024, and is expected to grow at a CAGR of 6.49% to reach USD 1.58 billion by 2030.

Emergency contraceptive pills, commonly called the “morning-after pill,” are a type of birth control method used to prevent pregnancy. Emergency contraceptive pills are not intended for regular use and should not be used as a substitute for other forms of contraception. The use of emergency contraceptive pills has increased in past years to prevent unintended pregnancies. In addition, the supportive government and non-profit organization’s efforts to increase awareness toward the use of emergency contraceptive pills have contributed to the market growth. The side effects of emergency contraceptive pills and concerns associated with the effectiveness of pills limit their use among the women of the U.S. population. However, the ongoing research and development activities for new product developments and the emergence of contraceptive pills on online channels are expected to create growth opportunities for the market in the U.S.

Regional Insights

The emergency contraceptive pills market in the United States is rapidly growing owing to the ability of pills to prevent unintended pregnancies, supportive government awareness programs, and ongoing advancements in product portfolios. As per the National Institute of Health (NIH), around 25% of women aged between 15 to 44 currently using contraception reported consuming the pill as their choice. Policies and regulations promote access to comprehensive contraceptive care and methods as a critical part of women's health care, ensuring the availability of these pills at reasonable and accessible contraceptive care and procedures. Moreover, the increasing awareness and availability of novel product portfolios online are expected to drive the growth of the emergency contraceptive pills market in the coming years.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Emergency Contraceptive Pills Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Emergency Contraceptive Pills Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Emergency Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Curae Pharma360 Inc., Foundation Consumer Healthcare, LLC, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer, Inc., Piramal Enterprises Ltd., Rapha Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Viatris Inc., Wockhardt USA LLC, and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Emergency Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Antiprogestin
  • Combination Pills
  • Progesterone Pills
• Category
  • Branded
  • Generic
• Age Group
  • 15-24
  • 25-34
  • 35-44
  • 45 and Above
• Distribution
  • Offline
  • Online

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

The report offers valuable insights on the following aspects

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

1. What is the market size and forecast of the Emergency Contraceptive Pills Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Emergency Contraceptive Pills Market?
3. What are the technology trends and regulatory frameworks in the Emergency Contraceptive Pills Market?
4. What is the market share of the leading vendors in the Emergency Contraceptive Pills Market?
5. Which modes and strategic moves are suitable for entering the Emergency Contraceptive Pills Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.